Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000895421-25-000489·C4 Therapeutics, Inc.
Schedule 13G ownership disclosure
C4 Therapeutics Inc
Common Stock · CUSIP: 12529R107
Event date: 2025-06-30
- Filing-level shares
- 4,750,383
- Percent of class
- 6.7%
- Morgan Stanley
Shares: 4,750,383 · Class: 6.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000489
- Form type
- SCHEDULE 13G/A
- Filer
- C4 Therapeutics, Inc.
- CIK
- CIK 1662579
- Filed
- Aug 07, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership